Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.

Department of Cancer Biology, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195, USA.
JAMA The Journal of the American Medical Association (Impact Factor: 29.98). 03/2005; 293(7):799-809. DOI: 10.1001/jama.293.7.799
Source: PubMed

ABSTRACT The accurate identification and interpretation of germline mutations in mismatch repair genes in colorectal cancer cases is critical for clinical management. Current data suggest that mismatch repair mutations are highly heterogeneous and that many mutations are not detected when conventional DNA sequencing alone is used.
To evaluate the potential of conversion analysis compared with DNA sequencing alone to detect heterogeneous germline mutations in MLH1, MSH2, and MSH6 in colorectal cancer patients.
Multicenter study with patients who participate in the Colon Cancer Family Registry. Mutation analyses were performed in participant samples determined to have a high probability of carrying mismatch repair germline mutations. Samples from a total of 64 hereditary nonpolyposis colorectal cancer cases, 8 hereditary nonpolyposis colorectal cancer-like cases, and 17 cases diagnosed prior to age 50 years were analyzed from June 2002 to June 2003.
Classification of family members as carriers or noncarriers of germline mutations in MLH1, MSH2, or MSH6; mutation data from conversion analysis compared with genomic DNA sequencing.
Genomic DNA sequencing identified 28 likely deleterious exon mutations, 4 in-frame deletion mutations, 16 missense changes, and 22 putative splice site mutations. Conversion analysis identified all mutations detected by genomic DNA sequencing--plus an additional exon mutation, 12 large genomic deletions, and 1 exon duplication mutation--yielding an increase of 33% (14/42) in diagnostic yield of deleterious mutations. Conversion analysis also showed that 4 of 16 missense changes resulted in exon skipping in transcripts and that 17 of 22 putative splice site mutations affected splicing or mRNA transcript stability. Conversion analysis provided an increase of 56% (35/63) in the diagnostic yield of genetic testing compared with genomic DNA sequencing alone.
The data confirm the heterogeneity of mismatch repair mutations and reveal that many mutations in colorectal cancer cases would be missed using conventional genomic DNA sequencing alone. Conversion analysis substantially increases the diagnostic yield of genetic testing for mismatch repair mutations in patients diagnosed as having colorectal cancer.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Colorectal cancer results from the accumulation of genetic and epigenetic alterations that transform colonic epithelial cells into colon adenocarcinoma cells. The loss of genomic stability appears to be a key molecular and pathogenetic step that occurs early in the tumorigenesis process and permits the acquisition of sufficient alterations in tumor suppressor genes and oncogenes in a clone of cells to result in cancer. Three predominant forms of genomic instability have been identified in colon cancer: 1) microsatellite instability (MSI), 2) chromosome instability (CIN), and 3) chromosomal translocations. Substantial progress has been made recently regarding potential causes of MSI and CIN in colorectal cancer. Furthermore, in addition to genomic instability, a form of epigenomic instability has been recently identified that results in the aberrant methylation of tumor suppressor genes. The discovery of the cause and role of genomic and epigenomic instability in colon cancer formation has the potential to yield more effective chemotherapy strategies for colon cancer.
    Current Colorectal Cancer Reports 03/2006; 2(2).
  • [Show abstract] [Hide abstract]
    ABSTRACT: The clinical management of individuals in families with germline mutations in mismatch repair (MMR) genes relies not only on the accurate identification of genetic alterations but also on the interpretation of their pathogenicity. The spectrum of genetic alterations in MMR genes that predispose to hereditary nonpolyposis colorectal cancer (HNPCC) is very diverse. Of all mutations, it is the most difficult to predict the effect of missense mutations on the function of the protein. Therefore it is not always clear whether a missense mutation is pathogenic or just a harmless polymorphism. A number of computational and experimental assays (in vivo and in vitro) have been developed to assess the functional significance of missense mutations in MMR genes. Despite the profusion of such assays, it is not clear that they are sufficiently sensitive and specific to serve as clinically applicable diagnostic tests for HNPCC.
    Current Colorectal Cancer Reports 01/2007; 3(4):191-198.
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Lynch syndrome, also referred to as hereditary nonpolyposis colorectal cancer, is the most common form of hereditary colorectal cancer, and is associated with a high incidence of multiple primary neoplasms in various organs. METHODS: A 79-year-old woman (patient 1) diagnosed with ascending colon cancer had a history of previous carcinomas of the uterus, stomach, uroepithelial tract, and colon. One year later, she developed a brain tumor (glioblastoma). A 54-year-old female (patient 2) was diagnosed with endometrial cancer and sigmoid colon cancer. Both patients underwent genetic evaluations independently. RESULTS: No mutations were found in an exon-by-exon analysis of genomic DNA by polymerase chain reaction (PCR) and reverse transcription (RT)-PCR. However, multiplex ligation-dependent probe amplification (MLPA) identified genomic duplication spanning from exon 7 to exon 14 of the MSH2 gene in both patients. Due to the presence of this characteristic gene duplication, their pedigrees were investigated further, and these showed that they are paternal half-sisters, consistent with paternal inheritance. CONCLUSION: Large genomic duplication from intron 6 through intron 14 in MSH2 is a very rare cause of Lynch syndrome and is difficult to identify with conventional methods. MLPA may be an alternative approach for detecting large-scale genomic rearrangements.
    Journal of Gastroenterology 04/2013; · 4.02 Impact Factor

Full-text (4 Sources)

Available from
May 30, 2014